AUSTRALIAN-GROWN.
GMP-CERTIFIED.
BUILT FOR HEALTHCARE.
Explore PharmaCrop’s established Australian portfolio across dried flower, oral liquid, pastilles and inhaled liquid.
FOUR DOSAGE FORMS. ONE TRUSTED PORTFOLIO.
An established Australian product portfolio spanning dried flower, oral liquid, pastilles and inhaled liquid.
Dried Flower
Australian-grown dried flower across the Noosa Selects and PharmaCrop Premium ranges.
VIEW DRIED FLOWER →Oral Liquid
Finished oral liquid products across established PharmaCrop formulations.
VIEW ORAL LIQUID →Inhaled Liquid
Finished inhaled liquid products within the PharmaCrop portfolio.
VIEW INHALED LIQUID →AUSTRALIAN-GROWN DRIED FLOWER
PharmaCrop’s Australian-grown dried flower portfolio is available across two distinct ranges: Noosa Selects and PharmaCrop Premium.
PharmaCrop’s dried flower range is Australian-grown and supported by controlled cultivation, pharmaceutical quality systems and an integrated manufacturing platform.
Across the Noosa Selects and PharmaCrop Premium ranges, PharmaCrop offers a broad selection of finished dried flower products across multiple strengths and product profiles.
Our Accessible Range
Redefining value, the Australian way.
Australian-grown dried flower combining local cultivation, consistent quality and accessible value across a broad range of strengths and profiles.
DISCOVER NOOSA SELECTS →Our Premium Range
Where Australian cultivation reaches its peak.
Hand-selected, Noosa-grown dried flower curated to meet elevated standards for flower quality and presentation.
DISCOVER PHARMACROP PREMIUM →.webp)
PHARMACROP ORAL LIQUID RANGE
PharmaCrop’s oral liquid portfolio forms part of its established Australian finished-product range, supported by integrated pharmaceutical manufacturing and quality systems. The range currently includes three finished oral liquid products.
Oral Liquid Range
3 Products- Isolate
- Broad Spectrum
- Balanced
PHARMACROP PASTILLES
The PharmaCrop portfolio includes a finished pastille formulation developed as part of its broader multi-dosage-form product range.
PHARMACROP INHALED LIQUID RANGE
PharmaCrop’s inhaled liquid portfolio expands the product range across an additional dosage form, with two finished products currently included in the portfolio.
FROM THOUSANDS OF POSSIBILITIES TO THE ONES THAT MAKE THE CUT.
PharmaCrop’s cultivation program combines genetic diversity, rigorous selection and controlled growing to identify cultivars suited to consistent Australian production.
1,000+
Genetics EvaluatedA broad starting pool of genetics gives our cultivation team the depth to search for differentiated genetics.
Phenohunting
Selecting For QualityGenetics are cultivated and assessed to identify standout characteristics and production potential.
Elite Selections
Only The Strongest ProgressPromising selections move forward for further evaluation and cultivation at scale.
Continuous Development
The Pipeline Keeps GrowingOngoing selection continues to expand the future opportunities available from our Australian cultivation program.
Ready To Explore A Commercial Partnership?
Connect with our team to discuss Australian-grown products, GMP manufacturing, commercial pathways and supply opportunities.